The timeline for Breathtec's Boneheaded Letter of Intent traces back to the abrupt announcement of Guy LaTorre's (former CEO) departure from Breathtec. In the wake of such announcement, I spoke to Alfred Wong (VP Communications) regarding said departure. Wong stated there was a falling out of opinions as it related to the future direction of Breathtec. Wong said the company was then looking to make an acquisition but Wong refused to go any further with details. Thereafter, Breathtec had a temporary jump in shareprice January 2018 surrounding the hype of Cannabix and Canadian MJ Laws. The months continued ticking off with no CEO replacement as Breathtec steered itself right back into a ditch. A new CEO was finally appointed to fill a 6 month vacancy. However, we still remained in the dark as to where things really stood at Breathtec. To date, we have not received a personal acknowledgement from our CEO regarding his personal commitment to and recognition of shareholders. I must say he arrived in very poor taste/style. As the new CEO, Chris Moreau was also the sitting CEO of Nash Pharmacueticals. A company for which very little was known about through it's website and remains even more vague/secretive to date. At the time Nash Pharmacueticals webpages we're up and before they went dark, I recall there being some form of marijuana connection to their pitch. Who knows what it is at this juncture beyond the claim of pursuing "repurposed" drugs for clinical trials. Nash Pharmacueticals has been laying in wait, preparing for this very moment as written in the LOI to take over Breathtec to pursue seemingly endless (7 count thus far) and expensive trials at the expense of common shareholder value in the company. They are positioning the Family and Friends to take half - half your shares then further dilute the company. The Reverse Split will create more shares than the current total. We can't stand for this brazen theft of Breathtec by a startup company with zero track record in their respective line of work. It's insane to think just because management deliberately turned it's back on shareholders and the company tumble end over end, that somehow it's true value is reflected in the current shareprice. The shareprice is simply reflective of a crooked management team, hellbent on neverending greed. Logic should tell anyone, if Cannabix and Breathtec has arrived at the same technology advancements at the same time, due to a shared commitment in resources, how does one nearly hit a perceived value of 300 Million USD and the other remains valued at 6 to 7 Million USD? It's not simply because of the markets their going after. It's one company actually being ran and not deliberately ran into the ground. I strongly implore management to rethink it's efforts before inking a deal in blood (our blood/common shareholders). Otherwise, it's my belief there will be red everywhere in the foreseeable future, and no one will come away unscathed.
Just saying...again
/////AMG
It's A Real Movie
Take Your Best Screenshot
